AngioDynamics, Inc.ANGONASDAQ
LOADING
|||
Switch Symbol:
R&D Expense Growth Accelerating
Trending higher, above historical average.
Left:
||||
Year-over-year research & development expense growth
Latest
21.05%
↑ 1644% above average
Average (39q)
1.21%
Historical baseline
Range
High:24.57%
Low:-18.78%
CAGR
NaN%
Modest growth trend
| Period | Value |
|---|---|
| Q4 2025 | 21.05% |
| Q3 2025 | -2.63% |
| Q2 2025 | -4.67% |
| Q1 2025 | 7.44% |
| Q4 2024 | 2.37% |
| Q3 2024 | -6.53% |
| Q2 2024 | -17.89% |
| Q1 2024 | -5.42% |
| Q4 2023 | 9.03% |
| Q3 2023 | 1.03% |
| Q2 2023 | 14.71% |
| Q1 2023 | 0.20% |
| Q4 2022 | -17.94% |
| Q3 2022 | 5.94% |
| Q2 2022 | 8.05% |
| Q1 2022 | -11.21% |
| Q4 2021 | 10.89% |
| Q3 2021 | -18.78% |
| Q2 2021 | 6.29% |
| Q1 2021 | -11.81% |
| Q4 2020 | 7.80% |
| Q3 2020 | 24.57% |
| Q2 2020 | -13.85% |
| Q1 2020 | 8.13% |
| Q4 2019 | 23.39% |
| Q3 2019 | -12.61% |
| Q2 2019 | -0.14% |
| Q1 2019 | -2.08% |
| Q4 2018 | -3.90% |
| Q3 2018 | 18.72% |
| Q2 2018 | -0.05% |
| Q1 2018 | 5.73% |
| Q4 2017 | -5.19% |
| Q3 2017 | -3.81% |
| Q2 2017 | 12.52% |
| Q1 2017 | 0.64% |
| Q4 2016 | -11.86% |
| Q3 2016 | -3.29% |
| Q2 2016 | 19.44% |
| Q1 2016 | -6.00% |